b
r
c
introduct
mortal
due
merscov
infect
common
especi
among
immunocompromis
patient
pathogenesi
transmiss
mode
viru
still
well
understood
name
viru
deriv
area
appear
genom
sequenc
use
develop
qrtpcr
assay
merscov
detect
retriev
first
detect
case
isol
employ
assay
target
variou
region
includ
area
upstream
envelop
gene
upe
use
screen
open
read
frame
orf
use
confirm
aim
studi
assess
use
merscov
specif
assay
screen
respiratori
sampl
anticip
possibl
spread
viru
region
method
respiratori
specimen
test
use
qualit
onestep
qrtpcr
genesig
human
coronaviru
mer
kit
result
test
sampl
neg
merscov
one
sampl
found
merscov
posit
conclus
genesig
human
coronaviru
mer
kit
use
screen
suspect
respiratori
case
middl
east
area
well
region
middl
east
respiratori
syndrom
mer
novel
coronaviru
first
discov
septemb
cellcultur
patient
death
pneumonia
june
saudi
arabia
assiri
et
al
mortal
due
merscov
infect
common
especi
among
immunocompromis
patient
alabdallat
et
al
coronavirus
largest
posit
singlestrand
rna
virus
genom
reach
kb
long
genom
entail
cap
structur
polyadenyl
end
occupi
two
larg
overlap
open
read
frame
orf
subissi
et
al
merscov
part
c
lineag
betacoronaviru
genu
relat
coronaviru
detect
bat
omrani
et
al
merscov
highli
homolog
merslik
cov
isol
dromedari
camel
african
neoromicia
capensi
bat
respect
although
merscov
known
zoonot
origin
pathway
transmiss
anim
reservoir
human
still
well
understood
howev
suggest
bat
camel
human
rout
could
explain
merscov
outbreak
human
due
emerg
camel
trade
equatori
africa
saudi
arabia
last
year
gralinski
baric
merscov
caus
sever
lower
respiratori
tract
infect
sometim
requir
admiss
intens
care
unit
patient
usual
respond
well
alpha
interferon
cyclosporin
treatment
howev
specif
antivir
vaccin
avail
merscov
ohnuma
et
al
case
countri
worldwid
infect
diagnos
merscov
sinc
june
almost
third
die
saad
et
al
c
patient
merscov
infect
tend
leukocytosi
lymphopenia
express
thrombocytopenia
coagulopathi
moreov
creatinin
level
lactat
dehydrogenas
alanin
aminotransferas
aspart
aminotransferas
level
may
elev
thu
impli
liver
kidney
diseas
van
den
brand
et
al
male
elderli
commonli
infect
merscov
femal
younger
peopl
humantohuman
transmiss
commun
mainli
healthcar
set
poor
infect
control
measur
implement
especi
intens
care
unit
overcrowd
patient
may
occur
saad
et
al
report
case
merscov
especi
one
report
europ
us
like
associ
travel
histori
middl
east
rate
transmiss
viru
infect
patient
household
contact
low
drosten
et
al
rapid
detect
implement
proper
infect
control
measur
two
essenti
step
limit
control
merscov
transmiss
healthcar
set
includ
appli
contact
airborn
precaut
wear
glove
gown
surgic
mask
upon
entri
room
merscov
infect
patient
isol
remov
person
protect
equip
upon
leav
room
zumla
hui
protect
measur
outsid
healthcar
set
includ
avoid
contact
dromedari
camel
host
merscov
restrain
drink
camel
urin
raw
milk
eat
raw
undercook
camel
meat
moreov
peopl
work
camel
must
wear
protect
cloth
facial
mask
maintain
good
person
hygien
reusken
et
al
ideal
lower
respiratori
specimen
sputum
bronchoalveolar
lavag
bronchial
wash
tracheal
aspir
repres
appropri
merscov
test
cdc
june
name
viru
deriv
area
appear
genom
sequenc
use
develop
qrtpcr
assay
merscov
detect
retriev
first
detect
case
isol
lu
et
al
employ
assay
target
variou
region
includ
area
upstream
envelop
gene
upe
use
screen
open
read
frame
orf
use
confirm
aim
studi
assess
use
merscov
specif
assay
screen
respiratori
sampl
refer
major
tertiari
care
center
anticip
possibl
spread
viru
region
rna
extract
respiratori
specimen
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
use
phenol
chloroform
extract
alcohol
precipit
protocol
briefli
lysi
buffer
use
isol
nondegrad
viral
rna
inactiv
rnase
sampl
transfer
qiaamp
mini
spin
column
optim
condit
ensur
effect
bind
rna
qiaamp
membran
possibl
contamin
remov
use
two
differ
wash
buffer
rnasefre
buffer
employ
elut
rna
merscoronaviru
qualit
onestep
qrtpcr
test
done
use
genesig
human
coronaviru
mer
kit
london
uk
hcov
primer
design
specif
exclus
vitro
detect
novel
coronaviru
isol
base
sequenc
emc
strain
target
upe
region
primer
probe
set
design
specif
mer
strain
regardless
speci
origin
detect
fam
channel
intern
rna
extract
control
avail
kit
ad
lysi
buffer
extern
sourc
rna
templat
extract
step
copurifi
sampl
rna
monitor
process
well
rule
presenc
inhibitor
realtim
pcr
step
latter
purpos
separ
mix
primer
intern
control
limit
concentr
allow
multiplex
target
sequenc
primer
without
affect
abil
detect
target
even
present
low
concentr
use
detect
intern
control
vic
channel
moreov
primer
mix
endogen
control
actin
beta
actb
gene
use
evalu
qualiti
origin
biolog
sampl
detect
actb
vic
channel
thu
separ
reaction
mix
target
necessari
test
actb
multiplex
actb
hcov
primer
possibl
sampl
three
reaction
mix
prepar
detect
two
reaction
tube
prepar
follow
qrtpcr
mastermix
primerprob
mix
intern
extract
control
primerprob
mix
rnasednas
free
water
rna
materi
detect
endogen
actb
control
separ
reaction
mix
prepar
contain
qrtpcr
mastermix
endogen
actb
primerprob
mix
rnasednas
free
water
rna
materi
amplif
condit
involv
revers
transcript
step
min
enzym
activ
step
min
cycl
follow
posit
control
well
neg
control
rnasednas
free
water
use
run
test
requir
min
handson
time
pcr
protocol
last
two
hour
rotorgeneq
qiagen
uk
softwar
use
analysi
test
sampl
neg
merscov
one
sampl
found
merscov
posit
posit
result
valid
naval
medic
research
unit
namru
laboratori
locat
cairoegypt
collabor
world
health
organ
result
valid
cap
accredit
referr
laboratori
germani
concord
rate
fig
repres
graph
amplif
merscov
rna
endogen
actb
merscov
posit
sampl
posit
neg
control
use
signal
detect
done
fam
channel
graph
fig
repres
detect
intern
rna
extract
control
iec
fluoresc
channel
vic
posit
sampl
iec
ad
sampl
extract
posit
neg
control
accept
ct
valu
iec
rang
genesig
human
coronaviru
mer
kit
rapid
use
kit
screen
suspect
respiratori
case
middl
east
area
well
region
collabor
differ
molecular
microbiolog
laboratori
world
health
organ
viral
cultur
done
gold
standard
refer
test
alway
reward
teach
experi
extens
sensit
specif
workup
perform
side
multipl
sampl
due
presenc
singl
merscov
posit
case
howev
lower
limit
detect
compat
copiesml
report
manufactur
clinician
advis
detect
limit
accept
manag
algorithm
knowledg
first
report
describ
clinic
applic
genesig
kit
merscov
epidem
era
